Assured Pharmacy Inc. (APHY) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Assured Pharmacy Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 15.76M 16.28M 16.44M 14.15M 5.19M
Cost of Goods Sold (COGS) incl. D&A 12.47M 15.35M 16.1M 14.18M 5.99M
COGS excluding D&A 12.25M 15.31M 16.07M 14.14M 5.96M
Depreciation & Amortization Expense 218,892 37,259 27,609 34,614 25,569
Depreciation 218,892 37,259 27,609 - -
Amortization of Intangibles - 0 0 - -
Gross Income 3.29M 925,653 346,246 (33,470) (796,939)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 6.11M 2.93M 3.11M 2.76M 2.1M
Research & Development 0 0 0 0 0
Other SG&A 6.11M 2.93M 3.11M 2.76M 2.1M
Other Operating Expense 0 0 0 0 0
Unusual Expense (539,573) 619,610 (426,351) (266,989) (1.74M)
EBIT after Unusual Expense 539,573 (619,610) 426,351 266,989 1.74M
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 730,679 375,272 918,333 1.48M 1.26M
Gross Interest Expense 730,679 375,272 918,333 1.48M 1.26M
Interest Capitalized 0 0 0 - 0
Pretax Income (3.01M) (3M) (3.26M) (4.01M) (2.42M)
Income Tax 0 0 0 0 328,080
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) (1.16M) (60,656) 0 0 (2.19M)
Consolidated Net Income (4.17M) (3.06M) (3.26M) (4.01M) (4.94M)
Minority Interest Expense 14,852 11,580 12,051 0 0
Net Income (4.19M) (3.07M) (3.27M) (4.01M) (4.94M)
Extraordinaries & Discontinued Operations (33,109) (4,928) 0 0 (609,292)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations (33,109) (4,928) 0 0 (609,292)
Net Income After Extraordinaries (4.22M) (3.08M) (3.27M) (4.01M) (5.55M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (4.19M) (3.07M) (3.27M) (4.01M) (4.94M)
EPS (Basic) (7.20) (2.48) (1.14) (0.96) (0.91)
Basic Shares Outstanding 574,621 1.24M 2.88M 4.15M 6.13M
EPS (Diluted) (7.20) (2.48) (1.14) (0.96) (0.91)
Diluted Shares Outstanding 574,621 1.24M 2.88M 4.15M 6.13M
EBITDA (2.6M) (1.97M) (2.74M) (2.76M) (2.87M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Assured Pharmacy Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 15.76M 16.28M 16.44M 14.15M 5.19M
Cost of Goods Sold (COGS) incl. D&A 12.47M 15.35M 16.1M 14.18M 5.99M
COGS excluding D&A 12.25M 15.31M 16.07M 14.14M 5.96M
Depreciation & Amortization Expense 218,892 37,259 27,609 34,614 25,569
Depreciation 218,892 37,259 27,609 - -
Amortization of Intangibles - 0 0 - -
Gross Income 3.29M 925,653 346,246 (33,470) (796,939)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 6.11M 2.93M 3.11M 2.76M 2.1M
Research & Development 0 0 0 0 0
Other SG&A 6.11M 2.93M 3.11M 2.76M 2.1M
Other Operating Expense 0 0 0 0 0
Unusual Expense (539,573) 619,610 (426,351) (266,989) (1.74M)
EBIT after Unusual Expense 539,573 (619,610) 426,351 266,989 1.74M
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 730,679 375,272 918,333 1.48M 1.26M
Gross Interest Expense 730,679 375,272 918,333 1.48M 1.26M
Interest Capitalized 0 0 0 - 0
Pretax Income (3.01M) (3M) (3.26M) (4.01M) (2.42M)
Income Tax 0 0 0 0 328,080
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) (1.16M) (60,656) 0 0 (2.19M)
Consolidated Net Income (4.17M) (3.06M) (3.26M) (4.01M) (4.94M)
Minority Interest Expense 14,852 11,580 12,051 0 0
Net Income (4.19M) (3.07M) (3.27M) (4.01M) (4.94M)
Extraordinaries & Discontinued Operations (33,109) (4,928) 0 0 (609,292)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations (33,109) (4,928) 0 0 (609,292)
Net Income After Extraordinaries (4.22M) (3.08M) (3.27M) (4.01M) (5.55M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (4.19M) (3.07M) (3.27M) (4.01M) (4.94M)
EPS (Basic) (7.20) (2.48) (1.14) (0.96) (0.91)
Basic Shares Outstanding 574,621 1.24M 2.88M 4.15M 6.13M
EPS (Diluted) (7.20) (2.48) (1.14) (0.96) (0.91)
Diluted Shares Outstanding 574,621 1.24M 2.88M 4.15M 6.13M
EBITDA (2.6M) (1.97M) (2.74M) (2.76M) (2.87M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
